Skip navigation
Speakers

The World’s Largest and Highest Acclaimed Event for CFOs, Controllers and Finance Executives within the Life Sciences Sector

March 20-22, 2017
  • Philadelphia, PA

Robert (Rob) Auslander, CPA, CGMA, MBA
Vice President, Technical Accounting and Policies
Valeant Pharmaceuticals International

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Kristine Ball
Former Chief Financial Officer
Relypsa

Lisa Banker
Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

Subin Baral
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

Larry Breen
Director of Financial Planning and Analysis/Revenue Analytics
Sunovion

Andrew B. Bressler, CFA
Managing Director, Global Research
Bank of America Merrill Lynch

Wesley Bricker
Chief Accountant
U.S. Securities & Exchange Commission

Winna Brown
Partner
Ernst & Young LLP

Matthew Busch
Director, Technical Accounting and External Reporting
Amgen

Aidan Byrne
Partner
RSM Ireland

Richard Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

George Carey
Executive Director
Ernst & Young LLP

Angela Celia
Managing Director
CFGI

Andreas Chrysostomou
Managing Director
Duff & Phelps

Carolee Clarke-Reid
Director, Global Tax Operation
Johnson & Johnson

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

Chris Cooper
Partner, National Audit Life Sciences and Health Care Leader
Deloitte & Touche LLP

James D’Arreca
Chief Accounting Officer
Allergan

Christine Davine
Deputy Managing Partner
Deloitte & Touche LLP

Vineeta Dinesh
Director, Acquisition & Divestiture
Johnson & Johnson

Jeffrey Draper
Senior Advisor on Corporate Financial Reporting
Eli Lilly & Co

Michelle Drozd
Deputy Vice President of Policy and Research
Pharmaceutical Research and Manufacturers of America (PhRMA)

Mark A. Drozdowski
Partner, Life Sciences — National Audit Leader
KPMG

Jeff Ellis
Life Sciences Professional Practice Director
Deloitte & Touche LLP

Cathy Engelbert
CEO
Deloitte LLP

Matt Eyles
Executive Vice President, Policy & Regulatory Affairs
America’s Health Insurance Plans (AHIP)

Joe Fitzgerald
Executive Director
Ernst & Young LLP

Susan Garfield
Partner
Ernst & Young LLP

Faith Glazier
Principal
Deloitte Consulting LLP

Matthew Gline
Senior Vice President, Finance and Business Operations
Roivant Sciences, Inc.

Russell Golden
Chairman
FASB

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

Sharon Greenlees
Vice President of Investor Relations
AbbVie

Harry Griendling
Founder and CEO
DoubleStar, Inc.

Shanti Gupta
Senior Manager
Ernst & Young LLP

Brian Halligan
Partner
Ernst & Young LLP

Arnie Hanish
former Chief Accounting Officer, Eli Lilly & Co;
current Biotech Board Member

Jeff Hendrey
Partner
PwC

Maria Teresa “Tessa” Hilado
Chief Financial Officer
Allergan (Invited)

Dennis Howell
Partner
Deloitte & Touche LLP

Mike Iwanski
Head of Technical Accounting and Technical Operations Controller
Shire

Brian Jobe
Partner
Deloitte

Ann Powell Judge
Chief Human Resources Officer
Bristol-Myers Squibb

Murray Kay
former Commercial Controller of Specialty Care
AbbVie Products, LLC

Iya Khalil
Co-Founder and Chief Commercial Officer
GNS Healthcare

Ira Klein
Senior Director of Healthcare Quality Strategy,
Strategic Customer Group, Janssen Pharmaceuticals;
former National Medical Director for Clinical Thought Leadership
in the Office of the Chief Medical Officer, Aetna

Timothy Kocses
Director of Corporate Technical Accounting
Bristol-Myers Squibb

Joyce LaViscount
Chief Financial Officer
Helius Medical

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals

David Levi
Executive Director, Global Business Controls,
Corporate Controller’s Office
Bristol-Myers Squibb

Peter Licata
Chief Financial Officer
Rising Pharmaceuticals

Mike Lombardo
Partner
Deloitte

Kelly MacDonald
Associate Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Kennen MacKay, PhD
Vice President, Biotechnology Research Analyst
Credit Suisse

Kevin MacKay
Assistant Corporate Controller
Pfizer Inc

Mike Makovec
Audit Senior Manager
Deloitte & Touche LLP

Ralph Marcello
US Biopharmaceutical Leader and Principal
Deloitte Consulting LLP

Jack Markey
Assistant Controller
Eisai, Inc.

Michael Mason
Vice President of Finance and Treasurer
Alnylam Pharmaceuticals

Jeffrey R. Miller
Director, Revenue Accounting and Contract Administration
Impax Labs

Steve Miller
Chief Medical Officer
Express Scripts

Joel Morales
Senior Vice President Generics and Global Operations Finance
Par Pharmaceutical

Troy Norris
Executive Director
Ernst & Young LLP

Robert Owens
Assistant Controller
Bristol-Myers Squibb

Graham Poles
Partner
PwC

Jim Quinlan
Partner
CFGI

Bryan Reasons
Chief Financial Officer
Impax Labs

Chris Reinholz
Senior Manager
Ernst & Young LLP

Justin A. Renz, CPA, MST, MBA
Executive Vice President and Chief Financial Officer
Karyopharm

Stephen Rivera
Worldwide Senior Director for Financial Compliance and Procedures
Johnson & Johnson

Bill Roberts
Partner
Ernst & Young LLP

James Rosenberg
Senior Assistant Chief Accountant in the
Office of Health Care and Insurance
U.S. Securities & Exchange Commission

Bruce Rucks
Partner
Deloitte

Rob Schmidt
Principal
RSM US LLP

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Anthony Sgammato
Partner
Ernst & Young LLP

Rebecca Shanahan
Chief Executive Officer
Avella Specialty Pharmacy

Greg Simon
Director
Biden Cancer Initiative at Biden Foundation

Joseph Sutter
Manager
Deloitte & Touche LLP

Chris Tirona
Interim Global Corporate Controller
Indivior PLC

Gerardo Ubaghs
Vice President (Life Sciences), Global Healthcare Investment Banking
Bank of America Merrill Lynch

Suketu “Suky” Upadhyay
Senior Vice President of Global Finance Operations
Bristol-Myers Squibb

Colin Wittmer
New York Metro Deals & Transaction Services Leader
PwC

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Pamela Yanakopulos
Partner, Capital Markets and Accounting Advisory Services
PwC

Lily Yang
Vice President of Finance and Accounting
Medivation

Karen Young
U.S. Pharmaceutical and Life Sciences Assurance Leader
PwC

Jillian Zandonella
Assurance Manager
PwC

Robert (Rob) Auslander, CPA, CGMA, MBA
Vice President, Technical Accounting and Policies
Valeant Pharmaceuticals International

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Kristine Ball
Former Chief Financial Officer
Relypsa

Lisa Banker
Northeast Life Sciences Transactions Market Leader
Ernst & Young LLP

Subin Baral
Senior Manager, Transaction Advisory Services
Ernst & Young LLP

Larry Breen
Director of Financial Planning and Analysis/Revenue Analytics
Sunovion

Andrew B. Bressler, CFA
Managing Director, Global Research
Bank of America Merrill Lynch

Wesley Bricker
Chief Accountant
U.S. Securities & Exchange Commission

Winna Brown
Partner
Ernst & Young LLP

Matthew Busch
Director, Technical Accounting and External Reporting
Amgen

Aidan Byrne
Partner
RSM Ireland

Richard Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

George Carey
Executive Director
Ernst & Young LLP

Angela Celia
Managing Director
CFGI

Andreas Chrysostomou
Managing Director
Duff & Phelps

Carolee Clarke-Reid
Director, Global Tax Operation
Johnson & Johnson

Chad Cohen
Chief Financial Officer
Adaptive Biotechnologies

Chris Cooper
Partner, National Audit Life Sciences and Health Care Leader
Deloitte & Touche LLP

James D’Arreca
Chief Accounting Officer
Allergan

Christine Davine
Deputy Managing Partner
Deloitte & Touche LLP

Vineeta Dinesh
Director, Acquisition & Divestiture
Johnson & Johnson

Jeffrey Draper
Senior Advisor on Corporate Financial Reporting
Eli Lilly & Co

Michelle Drozd
Deputy Vice President of Policy and Research
Pharmaceutical Research and Manufacturers of America (PhRMA)

Mark A. Drozdowski
Partner, Life Sciences — National Audit Leader
KPMG

Jeff Ellis
Life Sciences Professional Practice Director
Deloitte & Touche LLP

Cathy Engelbert
CEO
Deloitte LLP

Matt Eyles
Executive Vice President, Policy & Regulatory Affairs
America’s Health Insurance Plans (AHIP)

Joe Fitzgerald
Executive Director
Ernst & Young LLP

Susan Garfield
Partner
Ernst & Young LLP

Faith Glazier
Principal
Deloitte Consulting LLP

Matthew Gline
Senior Vice President, Finance and Business Operations
Roivant Sciences, Inc.

Russell Golden
Chairman
FASB

Tim Gordon
Global FAAS Life Sciences Leader
Ernst & Young LLP

Sharon Greenlees
Vice President of Investor Relations
AbbVie

Harry Griendling
Founder and CEO
DoubleStar, Inc.

Shanti Gupta
Senior Manager
Ernst & Young LLP

Brian Halligan
Partner
Ernst & Young LLP

Arnie Hanish
former Chief Accounting Officer, Eli Lilly & Co;
current Biotech Board Member

Jeff Hendrey
Partner
PwC

Maria Teresa “Tessa” Hilado
Chief Financial Officer
Allergan (Invited)

Dennis Howell
Partner
Deloitte & Touche LLP

Mike Iwanski
Head of Technical Accounting and Technical Operations Controller
Shire

Brian Jobe
Partner
Deloitte

Ann Powell Judge
Chief Human Resources Officer
Bristol-Myers Squibb

Murray Kay
former Commercial Controller of Specialty Care
AbbVie Products, LLC

Iya Khalil
Co-Founder and Chief Commercial Officer
GNS Healthcare

Ira Klein
Senior Director of Healthcare Quality Strategy,
Strategic Customer Group, Janssen Pharmaceuticals;
former National Medical Director for Clinical Thought Leadership
in the Office of the Chief Medical Officer, Aetna

Timothy Kocses
Director of Corporate Technical Accounting
Bristol-Myers Squibb

Joyce LaViscount
Chief Financial Officer
Helius Medical

Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals

David Levi
Executive Director, Global Business Controls,
Corporate Controller’s Office
Bristol-Myers Squibb

Peter Licata
Chief Financial Officer
Rising Pharmaceuticals

Mike Lombardo
Partner
Deloitte

Kelly MacDonald
Associate Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Kennen MacKay, PhD
Vice President, Biotechnology Research Analyst
Credit Suisse

Kevin MacKay
Assistant Corporate Controller
Pfizer Inc

Mike Makovec
Audit Senior Manager
Deloitte & Touche LLP

Ralph Marcello
US Biopharmaceutical Leader and Principal
Deloitte Consulting LLP

Jack Markey
Assistant Controller
Eisai, Inc.

Michael Mason
Vice President of Finance and Treasurer
Alnylam Pharmaceuticals

Jeffrey R. Miller
Director, Revenue Accounting and Contract Administration
Impax Labs

Steve Miller
Chief Medical Officer
Express Scripts

Joel Morales
Senior Vice President Generics and Global Operations Finance
Par Pharmaceutical

Troy Norris
Executive Director
Ernst & Young LLP

Robert Owens
Assistant Controller
Bristol-Myers Squibb

Graham Poles
Partner
PwC

Jim Quinlan
Partner
CFGI

Bryan Reasons
Chief Financial Officer
Impax Labs

Chris Reinholz
Senior Manager
Ernst & Young LLP

Justin A. Renz, CPA, MST, MBA
Executive Vice President and Chief Financial Officer
Karyopharm

Stephen Rivera
Worldwide Senior Director for Financial Compliance and Procedures
Johnson & Johnson

Bill Roberts
Partner
Ernst & Young LLP

James Rosenberg
Senior Assistant Chief Accountant in the
Office of Health Care and Insurance
U.S. Securities & Exchange Commission

Bruce Rucks
Partner
Deloitte

Rob Schmidt
Principal
RSM US LLP

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Anthony Sgammato
Partner
Ernst & Young LLP

Rebecca Shanahan
Chief Executive Officer
Avella Specialty Pharmacy

Greg Simon
Director
Biden Cancer Initiative at Biden Foundation

Joseph Sutter
Manager
Deloitte & Touche LLP

Chris Tirona
Interim Global Corporate Controller
Indivior PLC

Gerardo Ubaghs
Vice President (Life Sciences), Global Healthcare Investment Banking
Bank of America Merrill Lynch

Suketu “Suky” Upadhyay
Senior Vice President of Global Finance Operations
Bristol-Myers Squibb

Colin Wittmer
New York Metro Deals & Transaction Services Leader
PwC

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Pamela Yanakopulos
Partner, Capital Markets and Accounting Advisory Services
PwC

Lily Yang
Vice President of Finance and Accounting
Medivation

Karen Young
U.S. Pharmaceutical and Life Sciences Assurance Leader
PwC

Jillian Zandonella
Assurance Manager
PwC